Application of alkannin or derivative thereof in preparation of medicine for treating coronavirus infection
The invention discloses an application of alkannin or a derivative thereof in preparation of a medicine for treating coronavirus infection. A mutant strain comprises a delta mutant strain of human coronavirus SARS-CoV-2 and an Omberg mutant strain of human coronavirus SARS-CoV-2. The invention also discloses a pharmaceutical composition and application thereof. The pharmaceutical composition comprises two or more of alkannin or derivatives thereof. The shikonin or the derivative thereof disclosed by the invention has an obvious in-vitro inhibition effect on main protease of coronavirus and shows a broad-spectrum antiviral effect..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 03. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ZHANG JIN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-03, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 |
|---|
| Patentnummer: |
CN116983289 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018988261 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018988261 | ||
| 003 | DE-627 | ||
| 005 | 20240126101530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240126s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018988261 | ||
| 035 | |a (EPA)CN116983289 | ||
| 035 | |a (EPA)88522080 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ZHANG JIN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of alkannin or derivative thereof in preparation of medicine for treating coronavirus infection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-03, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 | ||
| 520 | |a The invention discloses an application of alkannin or a derivative thereof in preparation of a medicine for treating coronavirus infection. A mutant strain comprises a delta mutant strain of human coronavirus SARS-CoV-2 and an Omberg mutant strain of human coronavirus SARS-CoV-2. The invention also discloses a pharmaceutical composition and application thereof. The pharmaceutical composition comprises two or more of alkannin or derivatives thereof. The shikonin or the derivative thereof disclosed by the invention has an obvious in-vitro inhibition effect on main protease of coronavirus and shows a broad-spectrum antiviral effect. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LI JIAN |4 aut | |
| 700 | 0 | |a ZHOU XUELAN |4 aut | |
| 700 | 0 | |a ZHONG FANGLIN |4 aut | |
| 700 | 0 | |a ZHANG YUTING |4 aut | |
| 700 | 0 | |a LIN CHENG |4 aut | |
| 700 | 0 | |a ZENG PEI |4 aut | |
| 700 | 0 | |a LIU YINZHEN |4 aut | |
| 700 | 0 | |a WAN SHUANGYAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 03. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:03 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88522080/publication/CN116983289A1?q=CN116983289 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 03 |c 11 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 03 |c 11 | ||